Articles producció científica> Medicina i Cirurgia

Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening

  • Dades identificatives

    Identificador: imarina:9287416
    Autors:
    Romero-Aroca PBaget-Bernaldiz MSagarra RHervás EBlasco RMolina JMoreno EFGarcia-Curto E
    Resum:
    (1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM), screening programs of which have been affected by the COVID-19 pandemic. The aim of the present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our healthcare area (HCA). (2) Methods: We carried out a retrospective study of patients with DM who had attended the DR screening program between January 2015 and June 2022. We studied attendance, DM metabolic control and DR incidence. (3) Results: Screening for DR decreased in the first few months of the pandemic. The incidence of mild and moderate DR remained stable throughout the study, and we observed little increase in severe DR, proliferative DR and neovascular glaucoma during 2021 and 2022. (4) Conclusions: The current study shows that during the COVID-19 pandemic, screening program attendance decreased during the year 2020, which then recovered in 2021. Regarding the most severe forms of DR, a slight increase in cases was observed, beginning in the year 2021. Nevertheless, we aimed to improve the telemedicine systems, since the conditions of a significant proportion of the studied patients worsened during the pandemic; these patients are likely those who were already poorly monitored.
  • Altres:

    Autor segons l'article: Romero-Aroca P; Baget-Bernaldiz M; Sagarra R; Hervás E; Blasco R; Molina J; Moreno EF; Garcia-Curto E
    Departament: Medicina i Cirurgia
    Autor/s de la URV: Baget Bernaldiz, Marc / Blasco López, Ruth / MOLINA HINOJOSA, JOSE CARLOS / Romero Aroca, Pedro
    Paraules clau: Telemedicine Family physicians Epidemiology Diabetic retinopathy Diabetic macular edema Covid-19 epidemiology diabetic retinopathy diabetic macular edema covid-19
    Resum: (1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM), screening programs of which have been affected by the COVID-19 pandemic. The aim of the present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our healthcare area (HCA). (2) Methods: We carried out a retrospective study of patients with DM who had attended the DR screening program between January 2015 and June 2022. We studied attendance, DM metabolic control and DR incidence. (3) Results: Screening for DR decreased in the first few months of the pandemic. The incidence of mild and moderate DR remained stable throughout the study, and we observed little increase in severe DR, proliferative DR and neovascular glaucoma during 2021 and 2022. (4) Conclusions: The current study shows that during the COVID-19 pandemic, screening program attendance decreased during the year 2020, which then recovered in 2021. Regarding the most severe forms of DR, a slight increase in cases was observed, beginning in the year 2021. Nevertheless, we aimed to improve the telemedicine systems, since the conditions of a significant proportion of the studied patients worsened during the pandemic; these patients are likely those who were already poorly monitored.
    Àrees temàtiques: Medicine, general & internal Medicine (miscellaneous) Medicine (all)
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Adreça de correu electrònic de l'autor: marc.baget@urv.cat ruth.blasco@urv.cat pedro.romero@urv.cat
    Identificador de l'autor: 0000-0002-7061-8987
    Data d'alta del registre: 2024-09-21
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    Enllaç font original: https://www.mdpi.com/2077-0383/11/23/7121
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Journal Of Clinical Medicine. 11 (23):
    Referència de l'ítem segons les normes APA: Romero-Aroca P; Baget-Bernaldiz M; Sagarra R; Hervás E; Blasco R; Molina J; Moreno EF; Garcia-Curto E (2022). Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening. Journal Of Clinical Medicine, 11(23), -. DOI: 10.3390/jcm11237121
    DOI de l'article: 10.3390/jcm11237121
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2022
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Medicine (Miscellaneous),Medicine, General & Internal
    Telemedicine
    Family physicians
    Epidemiology
    Diabetic retinopathy
    Diabetic macular edema
    Covid-19
    epidemiology
    diabetic retinopathy
    diabetic macular edema
    covid-19
    Medicine, general & internal
    Medicine (miscellaneous)
    Medicine (all)
  • Documents:

  • Cerca a google

    Search to google scholar